Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078675 | SCV000110535 | benign | not specified | 2012-10-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311554 | SCV000846878 | benign | Inborn genetic diseases | 2014-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001719817 | SCV001948319 | benign | not provided | 2021-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001719817 | SCV002401638 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001719817 | SCV005279119 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000078675 | SCV000151851 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |